Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...
TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 ...
First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone ...
William Blair reiterated their outperform rating on shares of Alto Neuroscience (NYSE:ANRO – Free Report) in a report issued ...
Longeveron Inc. announced positive results from its Phase 2a CLEAR MIND clinical trial of laromestrocel (Lomecel-Bâ„¢), a cellular therapy for mild Alzheimer's disease, published in Nature Medicine.
Successful final overall survival data from the phase 2a trial of CAN-2409 in pancreatic cancer shows notable survival improvement, prompting plans for a larger clinical trial in this indication.
Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.
Glasgow, Scotland Wednesday, March 19, 2025, 09:00 Hrs [IST] ...
"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...
Phase 2a results demonstrated laromestrocel (Lomecel-B) improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer's diseaseThis encouraging clinical trial data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback